Mirum Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
334.42 |
451.70 |
530.71 |
634.06 |
760.61 |
881.69 |
| Przychód Δ r/r |
0.00% |
35.07% |
17.49% |
19.47% |
19.96% |
15.92% |
| Przychód (min) |
332.98 |
423.73 |
483.06 |
633.87 |
715.42 |
829.31 |
| Przychód (max) |
337.24 |
516.22 |
568.60 |
634.25 |
822.01 |
952.87 |
| EBITDA (średnia) |
-125.59 |
-169.63 |
-199.30 |
-238.12 |
-285.64 |
-331.11 |
| EBIT (średnia) |
-134.17 |
-181.22 |
-212.92 |
-254.38 |
-305.15 |
-353.73 |
| EBIT % |
-40.12% |
-40.12% |
-40.12% |
-40.12% |
-40.12% |
-40.12% |
| Zysk netto (średni) |
-77.34 |
-51.98 |
-23.02 |
42.14 |
66.06 |
129.26 |
| Zysk netto % |
-23.13% |
-11.51% |
-4.34% |
6.65% |
8.68% |
14.66% |
| EPS (średnia) |
-1.61 |
-1.09 |
-0.47 |
0.65 |
1.39 |
2.72 |
| Liczba analityków (Przychody) |
7 |
7 |
9 |
6 |
2 |
5 |
| Liczba analityków (EPS) |
7 |
7 |
8 |
5 |
2 |
1 |
| symbol |
MIRM |
MIRM |
MIRM |
MIRM |
MIRM |
MIRM |